a href="http://www.biomedrealty.com">www.biomedrealty.com and at www.earnings.com
, which will include an online slide presentation to accompany the call, or live by calling 800-599-9795 (domestic) or 617-786-2905 (international) with call ID number 17348989. The complete webcast will be archived for 30 days on both web sites. A telephone playback of the conference call will also be available from 1:00 p.m. Pacific Time on Thursday, November 4, 2010 until midnight Pacific Time on Tuesday, November 9, 2010 by calling 888-286-8010 (domestic) or 617-801-6888 (international) and using access code 40125473.
About BioMed Realty TrustBioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 82 properties, representing 144 buildings with approximately 12.1 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties include, without limitation: general risks affecting the real estate industry (including, without limitation, the inability to enter into or renew leases, dep
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Related biology technology :1
|SOURCE BioMed Realty Trust, Inc.|
Copyright©2010 PR Newswire.
All rights reserved
. Reportlinker Adds Next Generation U.S. and E.U. Biomaterials/BioMedical Devices: Market Trends & Commercial Implications2
. BioMed Realty Trust Completes South San Francisco Portfolio Acquisition3
. BioMed Realty Trust to Report 2010 Third Quarter Results4
. BioSpace and BioMed Central Create Global Career Community5
. DSM Biomedical Announces Continued Partnership with Spinelab6
. BioMed Realty Trust Declares Second Quarter 2010 Common Stock and Preferred Stock Dividends7
. BioMed Realty Trust Announces Planned Filing of Resale Registration Statement in Connection With 3.75% Exchangeable Senior Notes Due 20308
. BioMed Realty Trust Promotes Greg Lubushkin to Chief Financial Officer9
. BioMed Realty Trust Breaks Ground on 176,000 Square Foot R&D Facility for Isis Pharmaceuticals in Carlsbad, California10
. Biomedical Structures Receives Growth Capital from Ampersand Ventures to Fund Ongoing Expansion11
. BioMed Realty Trust to Webcast Company Presentation at Investor Day 2010